Insider Transactions in Q3 2024 at Gemini Therapeutics, Inc. (GMTX)
Insider Transaction List (Q3 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 16
2024
|
William Jacob Savage Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,500
-3.58%
|
$70,500
$47.41 P/Share
|
|
Sep 03
2024
|
William Richard White |
SELL
Open market or private sale
|
Direct |
1,957
-86.98%
|
$97,850
$50.89 P/Share
|
|
Sep 03
2024
|
William Richard White |
BUY
Exercise of conversion of derivative security
|
Direct |
1,957
+48.65%
|
$11,742
$6.26 P/Share
|
|
Sep 03
2024
|
William Jacob Savage Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,500
-3.46%
|
$75,000
$50.59 P/Share
|
|
Aug 01
2024
|
William Richard White |
SELL
Open market or private sale
|
Direct |
201
-85.82%
|
$8,643
$43.6 P/Share
|
|
Aug 01
2024
|
William Richard White |
BUY
Exercise of conversion of derivative security
|
Direct |
201
+50.0%
|
$1,809
$9.86 P/Share
|
|
Jul 08
2024
|
John D Quisel Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,000
+4.0%
|
$3,000
$1.01 P/Share
|
|
Jul 01
2024
|
William Richard White |
SELL
Open market or private sale
|
Direct |
201
-56.17%
|
$9,045
$45.81 P/Share
|
|
Jul 01
2024
|
William Richard White |
BUY
Exercise of conversion of derivative security
|
Direct |
201
+50.0%
|
$1,809
$9.86 P/Share
|